FDA's New Dissolution Methods Database Expected to Speed ANDA Approvals

Drug Industry Daily
KEYWORDS FDA / GPhA
A A

The FDA’s Office of Generic Drugs (OGD) has launched its Dissolution Methods Database aimed at improving the quality and turnaround time of abbreviated new drug applications (ANDAs).

To View This Article:

Login

Subscribe To Drug Industry Daily